Topics
Gliomas | Diagnosis | Liquid biopsy
Home > Publications > Topics > Gliomas > Diagnosis > Liquid biopsy
*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu
Y, Qi L.
Imaging and Liquid Biopsy for
Distinguishing True Progression From Pseudoprogression in Gliomas,
Current Advances and Challenges.
Acad Radiol. 2024 Apr
12:S1076-6332(24)00162-4. doi:
10.1016/j.acra.2024.03.019. PMID:
38614827. Review. ˍ
Mikolajewicz N, Yee PP, Bhanja D, Trifoi M, Miller AM, Metellus P,
Bagley SJ, Balaj L, de Macedo Filho LJM, Zacharia BE, Aregawi D,
Glantz M, Weller M, Ahluwalia MS, Kislinger T, Mansouri
A.
Systematic Review of Cerebrospinal
Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to
Standardization and Clinical Application.
J
Clin Oncol. 2024 Apr 12:JCO2301621. doi:
10.1200/JCO.23.01621. PMID:
38608213. Review˰ ˍ
*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu
Y, Qi L.
Imaging and Liquid Biopsy for
Distinguishing True Progression From Pseudoprogression in Gliomas,
Current Advances and Challenges.
Acad Radiol. 2024 Apr
12:S1076-6332(24)00162-4. doi:
10.1016/j.acra.2024.03.019. PMID:
38614827. Review. ˍ
Huang T, Sun F, Gao K, Wang Y, Zhu G, Chen F.
The
role of Peripheral Inflammatory Markers and Coagulation factors in
patients with CNS immune disease and glioma.
World
Neurosurg. 2024 May 17:S1878-8750(24)00843-X. doi:
10.1016/j.wneu.2024.05.080. PMID:
38763458. Observational study˰
ˍ
Papadimitrakis D, Perdikakis M, Gargalionis AN, Papavassiliou AG.
Biomarkers in Cerebrospinal Fluid for
the Diagnosis and Monitoring of Gliomas.
Biomolecules.
2024 Jul 5;14(7):801. doi:
10.3390/biom14070801. PMID:
39062515. Review. ˍ
Li B, Gao B, Zhu HJ, Luwor RB, Lu J, Zhang L, Kong B.
The
Prognostic Value of Preoperative Inflammatory Markers for
Pathological Grading of Glioma Patients.
Technol
Cancer Res Treat. 2024 Aug 5;23:15330338241273160. doi:
10.1177/15330338241273160. PMID:
39099463. Observational study. ˍ
Batool SM, Escobedo AK, Hsia T, Ekanayake E, Khanna SK, Gamblin
AS, Zheng H, Skog J, Miller JJ, Stemmer-Rachamimov AO, Cahill DP,
Balaj L, Carter BS.
Clinical utility of
a blood based assay for the detection of IDH1.R132H-mutant
gliomas.
Nat
Commun. 2024 Aug 16;15(1):7074. doi:
10.1038/s41467-024-51332-7. PMID:
39152110. Observational
study. ˍ
Detchou D, Barrie U.
Circulating
biomarkers literature in glioma patient populations.
Neurosurg
Rev. 2024 Aug 27;47(1):484. doi:
10.1007/s10143-024-02738-w. PMID:
39187709. Review˰ ˍ
**Löding S, Antti H, Sjöberg RL, Melin B, Björkblom
B.
Blood based metabolic markers of
glioma from pre-diagnosis to surgery.
Sci
Rep. 2024 Sep 5;14(1):20680. doi:
10.1038/s41598-024-71375-6. PMID:
39237693. Observational study. ˍ
Zhou J, Tan B, Gao F.
Prognostic
values of combined ratios of white blood
cells in glioma: a systematic review
and meta-analysis.
Neurosurg
Rev. 2024 Oct 31;47(1):831. doi:
10.1007/s10143-024-03064-x. PMID:
39477886. Review; Meta-analysis˰
ˍ